Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2020
ICER's assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine
Meg Franklin, Eric Druyts
AIDS (London, England)
|
May 31, 2013
Engaging men in HIV treatment and care
Eric Druyts, Edward J Mills
Journal of Clinical Epidemiology
|
July 4, 2020
Is it always possible to complete a systematic review in 2 weeks? Further thoughts and considerations
Kevin Yan, Chakrapani Balijepalli, Eric Druyts
Frontiers in Digital Health
|
October 29, 2021
The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks
Kevin Yan, Chakrapani Balijepalli, Eric Druyts
Journal of Medical Economics
|
April 8, 2014
Letter to the editor
Eric Druyts, Kristian Thorlund, Edward J Mills
Clinical Epidemiology
|
January 30, 2014
SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
Kristian Thorlund, Eric Druyts, Edward J Mills
Systematic Reviews
|
October 15, 2014
The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis
Eric Druyts, Shawn Eapen, Ping Wu, et al.
Pharmacoeconomics
|
September 14, 2020
On Pandemic Preparedness: How Well is the Modeling Community Prepared for COVID-19?
Kamal Desai, Eric Druyts, Kevin Yan, et al.
Current Medical Research and Opinion
|
September 13, 2021
Changing face of healthcare: digital therapeutics in the management of diabetes
Priyadharshini Ramakrishnan, Kevin Yan, Chakrapani Balijepalli, et al.
Journal of Medical Economics
|
January 29, 2015
Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis
Kabirraaj Toor, Eric Druyts, Jeroen P Jansen, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2020
ICER's assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine
Meg Franklin, Eric Druyts
AIDS (London, England)
|
May 31, 2013
Engaging men in HIV treatment and care
Eric Druyts, Edward J Mills
Journal of Clinical Epidemiology
|
July 4, 2020
Is it always possible to complete a systematic review in 2 weeks? Further thoughts and considerations
Kevin Yan, Chakrapani Balijepalli, Eric Druyts
Frontiers in Digital Health
|
October 29, 2021
The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks
Kevin Yan, Chakrapani Balijepalli, Eric Druyts
Journal of Medical Economics
|
April 8, 2014
Letter to the editor
Eric Druyts, Kristian Thorlund, Edward J Mills
Clinical Epidemiology
|
January 30, 2014
SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
Kristian Thorlund, Eric Druyts, Edward J Mills
Systematic Reviews
|
October 15, 2014
The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis
Eric Druyts, Shawn Eapen, Ping Wu, et al.
Pharmacoeconomics
|
September 14, 2020
On Pandemic Preparedness: How Well is the Modeling Community Prepared for COVID-19?
Kamal Desai, Eric Druyts, Kevin Yan, et al.
Current Medical Research and Opinion
|
September 13, 2021
Changing face of healthcare: digital therapeutics in the management of diabetes
Priyadharshini Ramakrishnan, Kevin Yan, Chakrapani Balijepalli, et al.
Journal of Medical Economics
|
January 29, 2015
Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis
Kabirraaj Toor, Eric Druyts, Jeroen P Jansen, et al.
Page
of 7